Company / Book Value per Share
Compass Therapeutics, Inc. Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.909
FY2024
5-year range
$0.909 / $2.228
FY2020-FY2024
Trend
-21.9%
vs FY2023
Sector context
#172 of 211
Health Care
What the data says
Compass Therapeutics, Inc.'s book value per share of $0.909 is lower than 82% of companies in the Health Care sector (FY2024). Book Value per Share has declined for 3 consecutive years, from $2.228 in FY2021 to $0.909 in FY2024.
Based on SEC 10-K filings.
$0.909 in FY2024 with a 5-year CAGR of -11.6%.
Declined from $1.438 to $0.909 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -25.8%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 211This company $0.909 Sector average $213.854
▼
-99.6% below sector average
Key checks
Key Insights
- Compass Therapeutics, Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of -11.6%, indicating a declining trend.
- In FY2024, book value per share decreased 21.9% year-over-year.
- Ranks #172 out of 211 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.909 | -21.9% |
| FY2023 | $1.163 | -19.1% |
| FY2022 | $1.438 | -35.5% |
| FY2021 | $2.228 | +71.7% |
| FY2020 | $1.298 | -22.9% |
| FY2019 | $1.684 | +109.9% |
| FY2018 | -$16.955 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026